Peláez-García, A., Yébenes, L., Berjón, A., Angulo, A., Zamora Auñón, M. d. P., Sánchez Méndez, J. I., . . . Hardisson Hernáez, D. A. (2017). Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
Citación estilo ChicagoPeláez-García, Alberto, et al. Comparison of Risk Classification between EndoPredict and MammaPrint in ER-positive/HER2-negative Primary Invasive Breast Cancer. 2017.
Cita MLAPeláez-García, Alberto, et al. Comparison of Risk Classification between EndoPredict and MammaPrint in ER-positive/HER2-negative Primary Invasive Breast Cancer. 2017.
Precaución: Estas citas no son 100% exactas.